Kristie Rosa
Articles
Cabozantinib/Atezolizumab Shows Promise in Treating Advanced HCC
July 04, 2021
Article
A combination of cabozantinib and atezolizumab improved the PFS in patients with Advanced HCC
Epoetin Alfa Biosimilar Launched at Significant Discount in US
November 21, 2018
Article
Epoetin alfa-epbx (Retacrit), the biosimilar to epoetin alfa (Procrit/Epogen), has been launched in the United States at a significant discount. The shipment of the biosimilar to wholesalers throughout the United States began on Nov. 12, 2018.
Advertisement
Advertisement